How do I tell if OBIO is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Stock

NASDAQ · OBIO

Trade OBIO

Fundamentals

Market cap

$343.80M

Price / Earnings ratio

-5.8x

Price / Sales ratio

10.8x

Price / Book ratio

17.8x

Return on assets

-55.0%

Dividend amount

$0.00

Dividend yield

0.00%

Source: third-party data provider, as of October 15, 2026

Compare with OBIO

Technical indicators

RSI 14: 47.05
MACD 12/26/9: 0.08
EMA 9 of MACD: 0.16
MACD histogram: -0.08
SMA 50: $5.45; Price above SMA 50
EMA 50: $5.46; Price above EMA 50
SMA 200: $4.46; Price above SMA 200
EMA 200: $4.69; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 14, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 3 analyst ratings

Strong Sell0

Sell0

Hold0

Buy3

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

No data available

Debt & Balance Sheet

No data available

Revenue to Profit

No data available

Earnings

No data available

Source: third-party data provider

About Orchestra BioMed Holdings, Inc. Ordinary Shares

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

SectorHealthcare

IndustryBiotechnology

Employees86

CEOMr. David P. Hochman

IPO DateAug 4, 2020

HeadquartersNew Hope, PA

Key Executives

Name	Title	Year Born
Mr. David P. Hochman	Founder, Chairman of the Board of Directors & CEO	1975
Mr. Darren R. Sherman	Founder, President, COO & Director	1971
Mr. Andrew Lawrence Taylor M.B.A.	Chief Financial Officer	1971
Mr. William Reed Little	Executive Vice President of Corporate Development & Strategy	1971
Ms. Lisa Daniels	Vice President of Human Resources	—
Dr. Yuval Hay Mika D.Sc, Ph.D.	GM & CTO of Bioelectronic Therapies	1959
Dr. Hans-Peter Stoll M.D., Ph.D.	Senior VP & Medical Director	—
Dr. Avraham Matityahu Fischer M.D.	Senior Vice President of Medical Affairs & Innovation	1956
Mr. Bob Laughner	Senior Vice President of Regulatory & Quality	—
Mr. Juan Lorenzo	Senior Vice President of Product Development	—

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "OBIO", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy OBIO by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Orchestra BioMed Holdings, Inc. Ordinary Shares from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track OBIO's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Stock

Fundamentals

Compare with OBIO

Recent news

OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?

Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?

Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?

These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

About Orchestra BioMed Holdings, Inc. Ordinary Shares

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade